TMCnet News

INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of PixarBio Corporation Investors
[February 02, 2017]

INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of PixarBio Corporation Investors


Law Offices of Howard G. Smith announces an investigation on behalf of PixarBio Corporation ("PixarBio" or the "Company") (Other OTC: PXRB) investors concerning the Company and its officers' possible violations of federal securities laws.

PixarBio is a specialty pharmaceutical/biotechnology company that focuses on the pre-clinical and clinical development of neurological drug delivery systems for post-operative pain.

On January 3, 2017, PixarBio's Chief Executive Officer, Frank Reynolds, disclosed that the Company had plans to acquire InVivo Therapeutics Holdings Corp. ("InVivo"). However, in response, InVivo stated that it had never been involved in any negotiations regarding a deal and rejected the offer.



Then on January 23, 2017, citing concerns about possible "manipulative or deceptive activities," the U.S. Securities and Exchange Commission froze trading of PixarBio shares. According to the SEC (News - Alert), "the market for the security appears to reflect manipulative or deceptive activities."

If you purchased PixarBio securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to [email protected], or visit our website at www.howardsmithlaw.com.


This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


[ Back To TMCnet.com's Homepage ]